Resveratrol as a Novel Therapeutic Agent for Treating Duchenne Muscular Dystrophy

Resveratrol as a Novel Therapeutic Agent for Treating Duchenne Muscular Dystrophy

Show other versions (1)

Duchenne Muscular Dystrophy (DMD) is an x-linked neuromuscular disease that is caused by an absence of dystrophin protein, rendering skeletal muscle more susceptible to contraction-induced damage. One therapeutic strategy focuses on increasing the expression of endogenous utrophin A, a dystrophin h...

Full description

Bibliographic Details
Main Author: Burt, Matthew
Other Authors: Jasmin, Bernard
Language:en
Published: Université d'Ottawa / University of Ottawa 2013
Subjects:
resveratrol
skeletal muscle
utrophin
dystrophin
mdx
duchenne muscular dystropy
slow oxidative myogenic program
sirt1
pgc-1 alpha
Online Access:http://hdl.handle.net/10393/26273
http://dx.doi.org/10.20381/ruor-3321

Internet

http://hdl.handle.net/10393/26273
http://dx.doi.org/10.20381/ruor-3321

Similar Items